Insights from 2023 EHA® Annual Meeting

 

Lymphoma
10:42

Insights from 2023 EHA® Annual Meeting

EHA® 2023 Insights: "Epcoritamab With Rituximab + Lenalidomide in Patients With High-Risk R/R FL"

FEATURING Anna Sureda
  • 44 views
  • July 17, 2023
02:18

Insights from 2023 EHA® Annual Meeting

2023 EHA® Insights: "Matching-Adjusted Indirect Comparison of Zanubrutinib vs. Ibrutinib in R/R MZL"

FEATURING Catherine Thieblemont
  • 61 views
  • July 6, 2023